FDA Slows Approval Of Affordable Cancer Drug In The Name Of Racial 'Equity' - The Daily Wire
An effective and more affordable treatment for lung cancer may not gain approval after the Food and Drug Administration complained about the lack of black people in its clinical trial, with the FDA’s top cancer official repeatedly noting in a meeting that it …
An effective and more affordable treatment for lung cancer may not gain approval after the Food and Drug Administration (FDA) complained about the lack of black people in its clinical trial, with a t… [+6735 chars]
Read More
Other Stories in Business
- Gulf War veteran executed for 1998 quadruple murder despite claims of mental illness
- Guardant Health (GH) Reports Strong Q1 2025 Revenue Growth
- Connecting Asia's startup ecosystem
- Connecting Asia's startup ecosystem
- From a Joke That Went Too Far to Radical Ideology – How Did the Memecoin Paradigm Change
- From a Joke That Went Too Far to Radical Ideology – How Did the Memecoin Paradigm Change
- L3Harris Technologies Stock: A Steady Course In A Changing World (NYSE:LHX)
- L3Harris Technologies Stock: A Steady Course In A Changing World (NYSE:LHX)
- Business First Bancshares, Inc. (BFST) Q1 2025 Earnings Call Transcript
